Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
REVENUE $ 537,000
OPERATING EXPENSES:    
Costs of revenue 151,000
Professional fees and related costs 219,000 298,000
General and administrative 669,000 781,000
Amortization of patents 30,000 83,000
TOTAL OPERATING EXPENSES 918,000 1,313,000
OPERATING LOSS (918,000) (776,000)
  OTHER INCOME:    
Interest and dividend income, net 431,000 310,000
Net realized and unrealized gain on marketable securities 48,000 364,000
Total other income, net 479,000 674,000
LOSS BEFORE INCOME TAXES AND EQUITY IN NET LOSSES OF EQUITY METHOD INVESTEE (439,000) (102,000)
INCOME TAX PROVISION:    
Current
Deferred taxes (147,000) (153,000)
Total income tax benefit (147,000) (153,000)
(LOSS) INCOME BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (292,000) 51,000
SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (628,000) (674,000)
NET LOSS $ (920,000) $ (623,000)
Net loss per share:    
Basic $ (0.04) $ (0.03)
Diluted $ (0.04) $ (0.03)
Weighted average common shares outstanding:    
Basic 23,540,468 23,866,821
Diluted 23,540,468 23,866,821